Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Not applicable Interventional

Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs

ClinicalTrials.gov ID: NCT01365429

Public ClinicalTrials.gov record NCT01365429. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 6:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Human donor lungs that do not meet the standard clinical criteria for donor lung utilization but fit into the study inclusion criteria will be retrieved from the donor using current donor lung retrieval techniques.

Study identification

NCT ID
NCT01365429
Recruitment status
Not listed
Study type
Interventional
Phase
Not applicable
Lead sponsor
XVIVO Perfusion
Industry
Enrollment
252 participants

Conditions and interventions

Interventions

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2011 (Type not available)
Primary completion
Dec 2017 (Actual)
Completion
Dec 2020 (Estimated)
Last update posted
Mar 7, 2018

2011 – 2020

United States locations

U.S. sites
18
U.S. states
15
U.S. cities
18
Facility City State ZIP Site status
Cedars-Sinai Medical Center Los Angeles California 90048 —
University of Colorado Aurora Colorado 80045 —
University of Florida-Gainesville Gainesville Florida 32610 —
Tampa General Hospital Tampa Florida 33606 —
University of Chicago Chicago Illinois 60631 —
Indiana University Health Indianapolis Indiana 46202 —
University of Maryland Baltimore Maryland 21201 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
University of Michigan Ann Arbor Michigan 48109 —
Henry Ford Detroit Michigan 48202 —
Barnes Jewish Hospital St Louis Missouri 63110 —
Columbia University Medical Centre New York New York 10032 —
Duke University Durham North Carolina 27710 —
Ohio State University Columbus Ohio 43210 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
University of Pittsburgh Pittsburgh Pennsylvania 15632 —
University of Texas Southwestern Dallas Texas 75390 —
University of Washington Medical Center Seattle Washington 98195 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01365429, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 7, 2018 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01365429 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →